Global Radiation Therapy Equipment Industry

Jan 09, 2014, 07:14 ET from Reportlinker

NEW YORK, Jan. 9, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Radiation Therapy Equipment Industry
http://www.reportlinker.com/p098399/Global-Radiation-Therapy-Equipment-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments:
Linear Accelerator,
Treatment Planning Systems,
and Radiation Therapy Simulator.

The report provides separate comprehensive analytics for the
US,
Canada,
Japan,
Europe,
Asia-Pacific,
Latin America,
Middle East and Africa,
and Latin America.

Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 45 companies including many key and niche players such as -
Accuray Inc.
BrainLab
Elekta AB
GE Healthcare
Hitachi America
IBA Group

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Linear Accelerator I-3
Treatment Planning System I-4
Radiation Therapy Simulator I-4

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1
Global Market for Radiotherapy - A Synopsis II-1
Current and Future Analysis II-2
Developing Nations Offer Lucrative Opportunities II-3
Table 1: Healthcare Spending as a Percentage of GDP in
Developing Countries (2012) (includes corresponding
Graph/Chart) II-4
Asia Presents a Promising Market II-4
US Leads in Penetration of LINACs II-5
Table 2: Global Linear Accelerators Installed Base (2012):
Penetration of Clinical Accelerators for Select Countries
(Installed Units per 1 Million Inhabitants) (includes
corresponding Graph/Chart) II-5
Ageing Population & Lifestyles Raise the Risk of Cancer II-5
Table 3: Worldwide Distribution of Population by Region/
Country (2012) (includes corresponding Graph/Chart) II-6
Table 4: Worldwide Distribution of 65+ Population by
Region/Country (2012) (includes corresponding Graph/Chart) II-7
Replacement Sales Lead Radiotherapy Market II-7
Table 5: Global Installed Base of LINACs (2012): Percentage
Share Breakdown by Volume of Units Installed for Europe,
Middle East & Africa, North & South America and Asia-Pacific
(includes corresponding Graph/Chart) II-8

2. MARKET TRENDS & ISSUES II-9
Demand for Oncology Information Systems on Rise II-9
Data-Intensive Radiation Oncology Promotes OIS Connection to
EHRs II-9
LINACS Increasingly Replace Conventional Equipment II-10
Hospitals Focus on Buying IMRT-Capable LINACs II-10
Types of IMRT II-11
Dynamic Multi Leaf Collimator IMRT II-11
Segmental Multi Leaf Collimator IMRT II-11
Image-Guided IMRT II-11
Rotational IMRT Gains Popularity II-11
Technological Innovations Improve Treatment Accuracy II-11
Personalized Radiation Therapy - The Way Forward II-12
Stereotactic Radio Surgery - A Treatment with Rising Preference II-12
Adaptive Radiation Therapy (ART) Gains Significance II-13
Treatment Planning - Grows in Significance II-13
IGRT Gaining Ground II-14
Shortage of Medical Professionals & Systems - A Major Obstacle II-14
Patient Comfort - A Significant Concern Affecting Treatment
Accuracy II-15
Cobalt-60 Units on a Decline II-15
Table 6: Cobalt-60 Units Distribution Worldwide by Geographic
Region (A Comparative Analysis of 1997 Vis-à-vis 2007):
Number of Units in Asia-Pacific, Eastern Europe, Central and
South America, Western Europe, North America, Middle East &
Africa, and Caribbean (includes corresponding Graph/Chart) II-16

3. PROTON THERAPY - AN INSIGHT II-17
Proton Therapy - Revolutionizing the Industry II-17
Table 7: World Recent Past, Current & Future Analysis for
Proton Therapy by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-18

Table 8: World 9-Year Perspective for Proton Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
and Rest of World Markets for Years 2010, 2013 & 2018
(includes corresponding Graph/Chart) II-19
Industry Marked by Intense Competition II-20
IMPT - The Future of Proton Therapy II-20
High Cost - A Barrier to Adoption II-20
Technological Advancement to Lower Cost of Therapy II-21

4. COMPETITION II-22
Competitive Landscape II-22
Table 9: Leading Global Players in Radiation Therapy
Equipment Market (2013E): Percentage Share Breakdown by Sales
for Varian, Elekta, Accuray, Siemens and Others (includes
corresponding Graph/Chart) II-23
Competition in the LINAC Segment II-23
Table 10: Leading Players in Global LINAC Market (2012):
Percentage Share Breakdown by Volume of Units Installed for
Varian, Elekta, Siemens and Others (includes corresponding
Graph/Chart) II-23
Stereotactic Radiosurgery Systems (SRS) - Market Scenario II-24
Table 11: Leading Players in SRS/SBRT Market (2013):
Percentage Share Breakdown by Volume Sales for Elekta,
BrainLab, Accuray and Others (includes corresponding

Graph/Chart) II-24
Proton Therapy - Overview of Competition II-24
Table 12: Leading Global Players in Proton Therapy Market
(2013): Percentage Share Breakdown by Operational Installed
Base for IBA, Hitachi, Mitsubishi, Varian and Sumitomo
(includes corresponding Graph/Chart) II-24
Treatment Planning Systems II-25
Table 13: Leading Players in Global Treatment Planning
Systems Market (2012): Percentage Share Breakdown by Value
Sales for Philips, Varian, Elekta and Others (includes
corresponding Graph/Chart) II-25

5. CANCER - A GLOBAL CONCERN II-26
Cancer Incidence - Statistics on New Cases II-26
Table 14: New Cancer Cases in the World by Affected Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-27

Table 15: Global Cancer Incidence by Income Group: 2012 (in
Thousands) (includes corresponding Graph/Chart) II-27

Table 16: Cancer Incidence in High Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-28

Table 17: Cancer Incidence in Upper Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-29

Table 18: Cancer Incidence in Lower Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-30

Table 19: Cancer Incidence in Low Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-31
Cancer Incidence in Developing Countries II-31
Cancer in Asia II-32
Cancer Cases - Mortality Rates II-32

6. RADIATION THERAPY: AN OVERVIEW II-33
Radiation Therapy - A Panacea for all Cancer Diseases II-33
Landmarks in Evolution of Cancer Care II-34
Radiation Therapy Treatment Team II-34
Types of Radiation Therapy II-34
External Beam Radiotherapy (EBRT) II-35
Conventional External Beam Radiotherapy II-35
Stereotactic Radiation II-35
Particle Therapy or Proton Therapy II-35
Auger Therapy II-36
Brachytherapy II-36
More About Brachytherapy II-36
Technical Scope of Brachytherapy II-37
Radiation Therapy for Treating Oral Cancer II-37
Other Forms of Radiation Therapy II-37
Photoradiation Therapy (PRT) II-37
Photodynamic Therapy (PDT) II-38
Cost of Radiation Therapy II-38
Limitations of Conventional Radiation Therapy Techniques II-38
Overview of Radiotherapy Equipment II-38
External Beam Therapy Devices II-38
CyberKnife II-39
Gamma Knife II-39
TomoTherapy II-39
LINACs II-40
Comparison of Select Radiotherapy Systems II-40
Proton Therapy Devices II-40

7. PRODUCT OVERVIEW II-41
Introduction II-41
Linear Accelerator II-41
Accelerator - Down to Nuts & Bolts II-41
Clinical Demands and Device Characteristics II-42
Dual X-ray Energy Linear Accelerator - Numerous Energy
Offerings II-43
Price - A Direct Functionality of Features II-43
Beam Energy and Dose Rates - Deciding Factors II-43
Isocentric Units - The Prevalent Form in Accelerators II-43
Subsystem Design Factors II-44
Bending Magnet Systems - For Smooth Functioning II-44
Dosimetry System - Regulating the Radiation Dosage II-45
Beam Steering Systems - Directing the Flow II-45
Cobalt-60 II-45
Characteristics of Cobalt-60 Machines II-45
Major features of Cobalt-60 Radioisotope II-46
Competitive Edge: Cobalt 60 Units vs. Linear Accelerators II-46
Comparative Assessment of Cobalt-60 Teletherapy Units and
Linear Accelerators II-46
Benefits of LINACs over Cobalt 60 Units II-47
Treatment Planning System: An Innovative Technique in
Radiation Therapy II-47
Radiation Therapy Simulator II-47
CT Simulation Systems II-48
Major Systems of Radiation Therapy Simulator II-49
Mechanical Systems II-49
Principles of Operations II-50

8. RADIOTHERAPY ACCESSORIES II-51
Introduction II-51
Tumor Localization and Treatment Simulation Devices II-51
Patient Restraint and Repositioning Devices II-51
Different Types of Patient Restraint and Repositioning Devices II-52
Patient Targeting System II-52
Field-Shaping Devices II-52
Dose-Modifying Devices II-53
Treatment Setup and Delivery Devices II-54
Breast Bridge with a Rolling-Ball Angle Inclinometer II-54
Squeeze Bridge Device II-54
Beam Alignment Device II-55
Arm Board II-55
Tilt Board II-55
Shoulder Reactor II-55
Mylar Window Table Insert II-55
Clamps II-55
Treatment Verification and Quality Assurance Devices II-55
Need for Surgery and Radiotherapy Likely to Diminish II-56

9. CANCER THERAPY - EPIDEMIOLOGY II-57
Four Progressive Stages of Cancer II-57
Types of Cancer II-57
Breast Cancer II-58
Treatment Options II-58
Major Developments in the Treatment Area of Breast Cancer II-58
Colorectal Cancer II-59
Prostate Cancer II-59
Pancreatic Cancer II-59
Cervical Cancer II-60
Esophageal Cancer II-60
Lung Cancer II-60
Treatment Options Available II-60
Technological Developments II-60
Cures II-60
Enhanced Therapies II-61
Prevention and Public Awareness II-61
Better Screening and Earlier Detection II-61
Other Emerging Therapies II-61

10. CANCER TREATMENT - A COST ANALYSIS II-62
Table 20: Cancer Treatment Costs by Modality II-62
Medicare and Medicaid Reimbursement II-62
Coverage II-63
Coding II-63
Payment II-63

11. NEW FRONTIERS IN RADIATION THERAPY II-64
Increasing Role of Imaging in Treatment Planning II-64
MRI to Attain Optimum Outcomes II-64
Positron Emission Tomography II-64
Convergence of PET and CT Images for Treatment Planning II-64
Dynamic contrast-enhanced CT/MRI II-65
Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone) PET (Cu-
ATSM PET) II-65
Four-Dimensional CT Scanning II-65
4D Adaptive Radiation Therapy - Adds a New Dimension II-65
MRI-Linacs - To Revolutionize Cancer Care II-65
Nano Particles in Cancer Treatment II-66
Microbeam Radiation Therapy Revisited II-67
Unleashing the Power of Plasma II-67
ION Beam Therapy Gains Attention II-67
Volumetric Modulated Arc Therapy (VMAT) II-68
Mobetron™ - Radiation Therapy on the Wheels II-68
3-D Conformal Radiation Therapy: A New Technology II-68
World's First 3-D Image-Guided Radiation Therapy System from
Elekta II-69
Evolving Technology Arms TomoTherapy with an Edge over
Competition II-69
High Dose Radiation Treatment Found to Reduce Side Effects in
Prostate Cancer Treatment II-69

12. PRODUCT INNOVATIONS/INTRODUCTIONS II-70
Elekta Launches Advanced Versa HD Linear Accelerator System II-70
Accuray Launches New TomoTherapy® H™ Series Technology II-70
MIM to Launch Co-branded Version of Mobile MIM 3.0 II-71
MIM Launches Upgraded Mobile MIM 3.0 II-71
Shimadzu and Hokkaido University Jointly Develop Cancer Cell-
Tracking System II-71
IZI Medical Launches Innovative Positioning Devices for
Radiation Therapy II-71
Elekta Introduces New XiO® Treatment Planning System and Focal
Contouring System II-72
Elekta Launches New Monaco® 3.0 DCA Treatment Planning System II-72
KAERI Develops Native High-Power Proton Accelerator II-72
E United Group to Introduce Radiation Equipment in Taiwan II-73
TomoTherapy Forges Alliance with NELCO to Offer Radiation
Shielding Solution II-73
Integra Unveils Upgraded Software for Radiotherapy Treatment II-73
Varian Medical Systems Unveils TrueBeam™ II-74
Elekta Unveils Monaco Version 2.03 II-74
Acceletronics Introduces Theraview KV Imaging IGRT System II-75
Nucletron Introduces Oncentra® Simulation 2.3 II-75
Siemens Healthcare Rolls Out ARTISTE Linear Accelerator II-75
MDS Nordion Introduces Enhanced TheraSphere® Administration
System II-75
VMS Showcases Recent Treatment Solution for Energy-Saving
Radiation Therapy II-76
VMS Introduces New Surgical Device for Inoperable Lung Cancer
Cases II-76

13. RECENT INDUSTRY ACTIVITY II-77
RTS Acquires OnCure Holdings II-77
Equra Health and Elekta Ink Long-term Agreement II-77
Radiation Oncology Resources and McKesson Specialty Health
Sign Multi-year Agreement II-77
Elekta Secures Order for Versa HD Systems from St. James's
Institute of Oncology II-78
RaySearch Laboratories and Hitachi Medical Sign Distribution
Agreement II-78
Spire Healthcare Enters into Partnership with Elekta II-79
Oncology Services International Enters into Partnership with
D3 Oncology Solutions II-79
Oncology Systems and IBA Dosimetry Sign Distribution Agreement II-79
IBA Partners Apollo Hospitals to Establish Proton Therapy Center II-80
e2v Bags Contract from Accuray II-80
Northern Centre for Cancer Care to Purchase TrueBeam™ Devices
from Varian II-80
Elekta Signs MoU with MSM-MEDIMPEX II-81
Institut Curie Selects Radiotherapy Systems of Varian Medical
Systems II-81
Varian Medical Systems Establishes Subsidiary in South Korea II-81
NHS Supply Chain Enters into Agreement with Elekta II-82
Varian Medical Systems Enters into Partnership with Siemens
Healthcare II-82

Elekta Takes Over Radon II-83
Varian Bags Order to Equip Proton Therapy Facility II-83
Varian Medical Systems Secures SFDA Approval for UNIQUE™
Medical Linear Accelerator II-83
Mevion Medical Systems Receives FDA Approval for MEVION S250
Proton Therapy System II-84
Varian Obtains FDA 510(k) Authorization for Radiotherapy
Treatment Planning Tool II-84
Accuray to Take Over Morphormics II-84
Accuray Inks Agreement with German Cancer Research Center II-84
Nordion Announces Launch of Gamma Centre of Excellence II-85
Overland Storage Bags Contract from Accuray for SnapServer N2000 II-85
Varian Takes Over Calypso II-85
Elekta Acquires Nucletron II-86
Accuray Acquires TomoTherapy II-86
Sensus Inks Contract for Superficial Radiotherapy with Premier
Healthcare II-86
Elekta and IBA Ink Proton Therapy Center Partnership II-87
MGH Opts for RaySearch's Treatment Planning Solution RayStation II-87
RaySearch Bags Order for RayStation from Advanced Radiation
Oncology Services II-87
Elekta Inks Agreement with Toshiba II-87
IMRIS and Varian Ink Agreement with NGHA II-88
Raysearch Signs Distribution Agreement with Kang Li II-88
Raysearch Grants Distribution Rights for RayStation to
Tecnologie Avanzate for Italian Market II-88
Elekta Signs Global Agreement with ScandiDos for Distribution
of Delta4PT Quality Assurance Tool II-89

TomoTherapy Signs Purchasing Agreement for Radiation Therapy
Equipment with ROi II-89
RaySearch and PMH Sign Exclusive License Agreement for
Deformable Image Registration Technology II-89
RaySearch Forms New Subsidiary, RaySearch Americas Inc. II-89
ViewRay Secures FDA Clearance to Commercialize MRI-Based
Radiation Therapy II-90
Brainlab Secures FDA Clearance for HybridArc Radiosurgery
Planning Solution II-90
Elekta Receives FDA Clearance for XiO Software II-90
Calypso Medical Obtains FDA 510(k) Clearance for Upgraded
Calypso System II-90
IsoRay Obtains Regulatory Approval for GliaSite II-91
BSD Medical Receives HDE Approval for BSD2000 Hyperthermia System II-91
RaySearch to Deliver Planning System to Health Quest Systems II-91
Varian Medical to Equip Lund University Hospital with TrueBeam
Radiotherapy Systems II-92
Calypso Medical Signs Distribution Agreement with Siemens II-92
IBt Bebig Acquires SonoTECH GmbH II-92
Elekta Inks Deal to Sell Stake in Motala Verkstad AB II-93
Kadambi Inks Agreement with Huiheng Medical for Marketing
Linear Accelerators II-93
Calypso Medical and Elekta Sign Agreement for Joint Product
Development II-93
Varian Receives FDA 510(k) Approval for Acuros® XB II-94
Premier Awards Contracts for Supply of Radiation Oncology
Products II-94
Accuray CyberKnife Obtains Shonin Certification II-94
Decimal Receives FDA Approval for New Electron Apertures for
Varian Treatment Equipment II-95
D3 Radiation's Radiation Therapy Error Reduction Service Gains
Nod from the American Board of Radiology II-95
TomoTherapy Bags Australian Contract II-95
Indo-American Cancer Institute Installs Elekta Compact™ Linear
Accelerator II-96
TomoTherapy Inks Purchasing Agreement with Amerinet II-96
Varian Supplies Radiotherapy Equipment and Software to Fortis

Oncology Centre II-96
Elekta Snaps Up Resonant Medical II-96
M-Cast and Block Imaging International Enter into Joint Venture II-97
Kirloskar Technologies and InSightec Ink Agreement II-97
ADAM Announces Commencement of First Unit of LIGHT II-98
Candelis Enters into Distribution Agreement with Siemens
Healthcare II-98
Calypso Enters into Master Development Agreement with Siemens
Healthcare II-99
Varian to Supply Radiotherapy Equipment to IPOP in Portugal II-99
Elekta Wins Contract to Supply Radiotherapy Systems to Cancer
Institute in Brazil II-100
Varian to Supply Radiotherapy Technology to Providence Health
and Services II-100
RaySearch Inks Agreement with WPE to Supply Proton Treatment
Planning System II-100
Centre Oscar Installs TomoTherapy® Hi•Art® Treatment System II-101
Glan Clywd Hospital to Install RapidArc™ Radiotherapy Technology II-101
University Hospitals in Switzerland and Germany Deploy RapidArc™ II-102
Nucletron Enters into Partnership with ART II-102
Hospitals in Sweden and Estonia Invest in Radiation Therapy
Systems II-102
SFDA Grants Approval to Elekta's Elekta Compact™ II-103
Elekta Bags Order from Velindre Cancer Centre II-103
Nucletron and Elekta Ink Agreement to Market Elekta's Software
System II-103
Helios Purchases Linear Accelerators from Varian Medical II-104
Oregon Health & Science University Purchases Monaco II-104
North American Scientific Inks Definitive Agreement with Best
Theratronics II-104
START Purchases Latest Technology to Treat Cancer II-105
M.D. Anderson Cancer Center Buys Leksell Gamma Knife Perfexion II-105
RaySearch Extends Collaboration with Nucletron II-105
AMS Inks Supply Contract with Smilow Cancer Hospital II-106
Elekta Collaborates with 'The Ottawa Hospital' II-106
TomoTherapy to Set Up TomoTherapy Unit at KFSH&RC II-107
Fujifilm Takes Over Empiric Systems II-107
Bruker Takes Over Varian's ACCEL Research Equipment Business II-107
Siemens and RaySearch Enter into Partnership II-108
American Shared Hospital Services to Establish Proton Beam
Radiation Therapy Facility II-108
IBt Inks JV Agreement with Santis and Rusnanotech II-108
Al Amal Hospital to Deploy Advanced Radiotherapy Solutions II-109
TomoTherapy Inks Distribution Agreement with Hitachi Medical II-109
Varian Purchases IKOEtech and IKOEmed II-109
Nucletron and Isodose Partner on Brachytherapy II-110

14. FOCUS ON SELECT KEY PLAYERS II-111
Accuray Incorporated (US) II-111
BrainLab (Germany) II-111
Elekta AB (Sweden) II-111
GE Healthcare (UK) II-112
Hitachi America (US) II-112
IBA Group (Belgium) II-113
Mitsubishi Electric Corporation (Japan) II-113
Nucletron B.V. (The Netherlands) II-114
Nordion, Inc. (Canada) II-114
Philips Healthcare (US) II-114
RaySearch (Sweden) II-115
Siemens Healthcare (Germany) II-115
Sumitomo Heavy Industries Ltd. (Japan) II-116
Varian Medical Systems, Inc. (US) II-116

15. GLOBAL MARKET PERSPECTIVE II-118
Table 21: World Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East &
Africa and Latin American Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) II-118

Table 22: World Historic Review for Radiation Therapy
Equipment by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East & Africa and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-119

Table 23: World 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East & Africa and Latin American Markets for
Years 2004, 2013 & 2018 (includes corresponding Graph/Chart) II-120

Table 24: World Recent Past, Current & Future Analysis for
Linear Accelerators by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East & Africa
and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2010 through 2018
(includes corresponding Graph/Chart) II-121

Table 25: World Historic Review for Linear Accelerators by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East & Africa and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-122

Table 26: World 15-Year Perspective for Linear Accelerators by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East & Africa and Latin American Markets for Years
2004, 2013 & 2018 (includes corresponding Graph/Chart) II-123

Table 27: World Recent Past, Current & Future Analysis for
Treatment Planning Systems by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East &
Africa and Latin American Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) II-124

Table 28: World Historic Review for Treatment Planning Systems
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East & Africa and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-125

Table 29: World 15-Year Perspective for Treatment Planning
Systems by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East & Africa and Latin American Markets for
Years 2004, 2013 & 2018 (includes corresponding Graph/Chart) II-126

Table 30: World Recent Past, Current & Future Analysis for
Radiation Therapy Simulators by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle
East & Africa and Latin American Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) II-127

Table 31: World Historic Review for Radiation Therapy
Simulators by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East & Africa and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-128

Table 32: World 15-Year Perspective for Radiation Therapy
Simulators by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East & Africa and Latin American
Markets for Years 2004, 2013 & 2018 (includes corresponding
Graph/Chart) II-129

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Market Overview III-1
Radiation Therapy Market - An Insight III-1
Table 33: US Market for Hospital Cancer Therapies (2004 &
2010): Percentage Breakdown of Revenues by Treatment Type -
Surgery, Chemotherapy Drugs, Radiation Therapy,
Biotechnology-Based Drugs, and Others (includes
corresponding Graph/Chart) III-2
Replacements Drive Unit Installations III-3
Table 34: US Linacs Installed Base (2012): Percentage
Share Breakdown by Age of Equipment (includes
corresponding Graph/Chart) III-3
EHR Incentive Program Promotes Improvements in Efficiencies III-3
Recession Brings in More Worries for Cancer Patients III-4
Demographics Drive Radiation Therapy Market III-4

IMRT Market III-5
Innovations Propel Market Growth III-5
Demand on Rise for Treatment Planning Software III-6
Competition III-6
Table 35: Leading Players in US Market for Radiation
Therapy Equipment (2013E): Percentage Share Breakdown by
Volume Sales for Varian, Elekta and Accuray (includes
corresponding Graph/Chart) III-7

Table 36: Leading Players in US Market for Radiation
Therapy Equipment (2013): Percentage Share Breakdown by
Installed Base for Varian, Elekta, Accuray and Siemens
(includes corresponding Graph/Chart) III-7
Cancer Stats III-7
Table 37: New Cancer Cases in the US by Gender and Affected
Site: 2012 III-7

Table 38: New Cancer Cases in Males in US by Leading Site:
2012 (includes corresponding Graph/Chart) III-9

Table 39: New Cancer Cases in Females in US by Leading
Site: 2012 (includes corresponding Graph/Chart) III-10

Table 40: New Cancer Cases in US by State: 2012 (includes
corresponding Graph/Chart) III-11

Table 41: New Cancer Cases in US by Age Group: 2012
(includes corresponding Graph/Chart) III-12
Cases III-12
Cancer Mortality Statistics III-13
Table 42: Cancer Related Deaths in the US by Gender and
Affected Site: 2012 III-13

Table 43: Cancer Related Deaths in Males in US by Leading
Site: 2012 (includes corresponding Graph/Chart) III-15

Table 44: Cancer Related Deaths in Females in US by Leading
Site: 2012 (includes corresponding Graph/Chart) III-16

Table 45: Cancer Related Deaths in US by State: 2012
(includes corresponding Graph/Chart) III-17

Table 46: Cancer Related Deaths in US by Age Group: 2012
(includes corresponding Graph/Chart) III-18
Reimbursement Scenario III-18
Product Launches III-20
Strategic Corporate Developments III-21
Key Players III-27
B.Market Analytics III-30
Table 47: US Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-30

Table 48: US Historic Review for Radiation Therapy Equipment
by Product Segment - Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-31

Table 49: US 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-32

Table 50: US Recent Past, Current & Future Analysis for
Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-33

2. CANADA III-34
A.Market Analysis III-34
Current and Future Analysis III-34
Market Led by Replacement III-34
Cancer Statistics in Canada III-35
Table 51: New Cancer Cases in Canada by Gender and Affected
Site: 2012 (includes corresponding Graph/Chart) III-35

Table 52: New Cancer Cases in Canada by Province: 2012
(includes corresponding Graph/Chart) III-36

Table 53: New Cancer Cases in Canada by Age Group: 2012
(includes corresponding Graph/Chart) III-37

Table 54: Cancer Related Deaths in Canada by Gender and
Affected Site: 2012 (includes corresponding Graph/Chart) III-38

Table 55: Cancer Related Deaths in Canada by Province: 2012
(includes corresponding Graph/Chart) III-39

Table 56: Cancer Related Deaths in Canada by Age Group:
2012 (includes corresponding Graph/Chart) III-40
Product Launches III-40
Strategic Corporate Development III-41
Key Player III-41
B.Market Analytics III-42
Table 57: Canadian Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-42

Table 58: Canadian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-43

Table 59: Canadian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-44

3. JAPAN III-45
A.Market Analysis III-45
Current and Future Analysis III-45
Radiation Therapy Market - An Overview III-45
Table 60: Leading Players in Japanese Radiation Therapy
Market (2012): Percentage Share Breakdown by Volume Sales
for Varian, Elekta, BrainLab and Accuray (includes
corresponding Graph/Chart) III-45
Product Launch III-46
Strategic Corporate Developments III-46
Select Players III-47
B.Market Analytics III-48
Table 61: Japanese Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-48

Table 62: Japanese Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-49

Table 63: Japanese 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-50

Table 64: Japanese Recent Past, Current & Future Analysis
for Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-51

4. EUROPE III-52
A.Market Analysis III-52
Current and Future Analysis III-52
Under-provision of Radiotherapy Units Offer New Opportunities III-52
Table 65: Europe Market for Radiation Therapy Equipment
(2012): Percentage Share Breakdown by Number of Treatment
Facilities for Germany, France, Italy, Spain and Others
(includes corresponding Graph/Chart) III-53
Cancer Stats III-53
Table 66: Cancer Incidence in Europe by Site: 2012 (in
Thousands) (includes corresponding Graph/Chart) III-54

Table 67: Western Europe Radiation Therapy Market (2012):
Percentage Market Share Breakdown for Leading Players -
Elekta, Varian, Tomotherapy, Accuray, and Others (includes
corresponding Graph/Chart) III-55
Strategic Corporate Development III-55
B.Market Analytics III-56
Table 68: European Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-56

Table 69: European Historic Review for Radiation Therapy
Equipment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-57

Table 70: European 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2004, 2013 & 2018
(includes corresponding Graph/Chart) III-58

Table 71: European Recent Past, Current & Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-59

Table 72: European Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-60

Table 73: European 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-61

Table 74: European Recent Past, Current & Future Analysis
for Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-62

4a. FRANCE III-63
A.Market Analysis III-63
Current and Future Analysis III-63
B.Market Analytics III-63
Table 75: French Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-63

Table 76: French Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-64

Table 77: French 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-65

4b. GERMANY III-66
A.Market Analysis III-66
Current and Future Analysis III-66
Strategic Corporate Developments III-66
Key Players III-67
B.Market Analytics III-68
Table 78: German Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-68

Table 79: German Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-69

Table 80: German 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-70

4c. ITALY III-71
A.Market Analysis III-71
Current and Future Analysis III-71
Strategic Corporate Development III-71
B.Market Analytics III-72
Table 81: Italian Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-72

Table 82: Italian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-73

Table 83: Italian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-74

4d. THE UNITED KINGDOM III-75
A.Market Analysis III-75
Current and Future Analysis III-75
Strategic Corporate Developments III-75
B.Market Analytics III-77
Table 84: The UK Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-77

Table 85: The UK Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-78

Table 86: The UK 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-79

4e. SPAIN III-80
A.Market Analysis III-80
Current and Future Analysis III-80
B.Market Analytics III-80
Table 87: Spanish Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-80

Table 88: Spanish Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-81

Table 89: Spanish 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-82

4f. RUSSIA III-83
A.Market Analysis III-83
Current and Future Analysis III-83
Strategic Corporate Development III-83
B.Market Analytics III-84
Table 90: Russian Recent Past, Current & Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-84

Table 91: Russian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-85

Table 92: Russian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2004,
2013 & 2018 (includes corresponding Graph/Chart) III-86

4g. REST OF EUROPE III-87
A.Market Analysis III-87
Current and Future Analysis III-87
Product Launches III-87
Strategic Corporate Developments III-88
Key Players III-89
B.Market Analytics III-92
Table 93: Rest of Europe Recent Past, Current & Future
Analysis for Radiation Therapy Equipment by Product Segment -
Linear Accelerator, Treatment Planning Systems, and
Radiation Therapy Simulators Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-92

Table 94: Rest of Europe Historic Review for Radiation
Therapy Equipment by Product Segment - Linear Accelerator,
Treatment Planning Systems, and Radiation Therapy Simulators
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-93

Table 95: Rest of Europe 15-Year Perspective for Radiation
Therapy Equipment by Product Segment - Percentage Breakdown
of Value Sales for Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets for Years
2004, 2013 & 2018 (includes corresponding Graph/Chart) III-94

5. ASIA-PACIFIC III-95
A.Market Analysis III-95
Current and Future Analysis III-95
Asia - A Potential Market for Radiation Therapy Equipment III-95
Table 96: Population Statistics in Asia (Including Japan) &
Percentage of Population Aged Above 65 Years (includes
corresponding Graph/Chart) III-96

Table 97: Installed Base of Clinical Accelerators in Asia
(Including Japan) Year (includes corresponding
Graph/Chart) III-97

Table 98: Market Potential for Clinical Accelerators in
Asia (Including Japan


To order this report: Global Radiation Therapy Equipment Industry
http://www.reportlinker.com/p098399/Global-Radiation-Therapy-Equipment-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com